Schedule 13G ownership disclosure

RAPT THERAPEUTICS INC

Security class unavailable · CUSIP: 75382E109

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,444,199
Percent of class
15.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-019460
Form type
SC 13G
Filer
Kleiner Perkins Caufield & Byers XV, LLC
CIK
CIK 1547840
Filed
Feb 13, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub